Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry (PA-IPF)
This study is currently recruiting participants.
Verified by University of Pittsburgh, May 2008
Sponsors and Collaborators: University of Pittsburgh
Temple University
University of Pennsylvania
Geisinger Clinic
Milton S. Hershey Medical Center
Information provided by: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00540475
  Purpose

The Pennsylvania Interstitial Lung Disease State-wide Research Registry (PA-ILD) is a cooperative project between five medical centers to coordinate a team of investigators. The aim of this registry will be: 1) To assess the extent of lung fibrosis in the commonwealth of Pennsylvania 2) To provide better access of patients with pulmonary fibrosis in all regions of Pennsylvania to standard of care and diagnosis 3) To facilitate the translation of new therapeutic interventions from the bench to the bedside.


Condition
Idiopathic Pulmonary Fibrosis

MedlinePlus related topics: Pulmonary Fibrosis
U.S. FDA Resources
Study Type: Observational
Study Design: Case Control
Official Title: The Pennsylvania Interstitial Lung Disease State-Wide Research Registry

Further study details as provided by University of Pittsburgh:

Estimated Enrollment: 9999
Study Start Date: September 2007
Estimated Study Completion Date: July 2010
Detailed Description:

The University of Pittsburgh Medical Center, Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease is the coordination center for the Pennsylvania Idiopathic Pulmonary Fibrosis Statewide Research Registry, the collaborative institutions include: the University of Pennsylvania Health System, Geisinger Health System, and Penn State Milton S. Hershey Medical Center.

The PA-IPF Registry developed into a web site that contains information for patients, health professionals, and families, as well as an Internet-based database that will store information about patients to provide them with guidance about care, research, and support groups close to the area in which they live.

Benefits for membership in the PA-IPF Registry include:

  • Staying informed about IPF research news, both nationally and locally.
  • Having advance notice of any IPF research in which patients may be eligible to participate.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients diagnosed with Idiopathic Pulmonary Fibrosis (IPF)

Criteria

Inclusion Criteria:

  • IPF diagnosis
  • Sufficient testing results completed for an IPF Diagnosis (screening script)
  • Adults (age > 18 years old)
  • Participants who read and comprehend English language

Exclusion Criteria:

  • Children
  • Prisoner-patients
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00540475

Contacts
Contact: Trisha R Black, BA 1-866-9224IPF blacktr@upmc.edu
Contact: Mindy J Seagriff, BA 412-802-6860 seagriffmj@upmc.edu

Locations
United States, Pennsylvania
Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Trisha R Black, B.A.     412-605-1550     blacktr@upmc.edu    
Contact: Kathleen O Lindell, PhD     412-802-3274     lindellko@upmc.edu    
Principal Investigator: Naftali Kaminski, M.D.            
Temple University Recruiting
Philadelphia, Pennsylvania, United States, 19140
Contact: Anne Marie Kuzma, RN     215-707-4327     annemarie.kuzma@tuhs.temple.edu    
Principal Investigator: Gerard Criner, M.D.            
The Center for Health Research at Giesinger Health System Not yet recruiting
Wilkes Barre, Pennsylvania, United States, 18711
Contact: Mary Ann Blosky, RN     570-214-9544     mblosky@geisinger.edu    
Principal Investigator: David E Fisk, M.D.            
Milton S. Hershey Medical Center Not yet recruiting
Hershey, Pennsylvania, United States, 17033
Contact: Rebecca Bascom, M.D.     717-531-6525     rbascom@psu.edu    
Contact: Michael Benninghoff, M.D.         mikebenninghoff@yahoo.com    
Principal Investigator: Rebecca Bascom, MD            
University of Pennsylvania Health System Not yet recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Susan Metzger, RN     215-662-3115     susan.metzger@uphs.upenn.edu    
Contact: Debra Smith     215-615-0276     debra.smith@uphs.upenn.edu    
Principal Investigator: Gergory Tino, M.D.            
Geisinger Wyoming Valley- Pulmonary Medicine Not yet recruiting
Wilkes Barre, Pennsylvania, United States, 18711
Contact: Angela DeAntonio, M.D.     570-820-6111     adeantonio@geisinger.edu    
Sponsors and Collaborators
University of Pittsburgh
Temple University
University of Pennsylvania
Geisinger Clinic
Milton S. Hershey Medical Center
Investigators
Principal Investigator: Naftali Kaminski, MD Director, Dorothy P. & Richard P. Simmons Center
  More Information

Pennsylvania Idiopathic Pulmonary Fibrosis Registry  This link exits the ClinicalTrials.gov site

Responsible Party: Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry ( Naftali Kaminski )
Study ID Numbers: PRO07040328
Study First Received: October 3, 2007
Last Updated: May 14, 2008
ClinicalTrials.gov Identifier: NCT00540475  
Health Authority: United States: Institutional Review Board

Keywords provided by University of Pittsburgh:
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease

Study placed in the following topic categories:
Lung Diseases, Interstitial
Respiratory Tract Diseases
Fibrosis
Hamman-Rich syndrome
Lung Diseases
Pulmonary Fibrosis

Additional relevant MeSH terms:
Pathologic Processes

ClinicalTrials.gov processed this record on January 14, 2009